Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

Open Offer Excess

26 Jul 2017 11:21

RNS Number : 1518M
Surface Transforms PLC
26 July 2017
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

26 July 2017

 

Surface Transforms Plc.

("Surface Transforms" or the "Company")

 

Open Offer Excess

 

Subsequent to the Open Offer of July 6 and as announced on July 25, applications were received for 5,091,616 Open Offer Shares, representing a take-up of 157.84 per cent that was scaled back to 3,225,806 Open Offer Shares. The Company also announced that it was exploring alternative avenues to satisfy this additional excess demand.

 

The Board is able to use its discretionary powers to issue up to 10% of the share capital in any year, as granted by shareholders  at the general meeting of the Company held yesterday, and intends to use this authority to offer to allot 1,865,810 shares at 15.5p per share to those shareholders who applied for an excess of their entitlement in the Open Offer but were scaled back on their applications.

 

As a result up to 1,865,810 new ordinary shares of 1 pence each in the Company ("Ordinary Shares") will be admitted to trading on 10 August 2017.

 

To this end the Company is writing to this limited number of shareholders and asking them to inform the Company if they do not wish to continue with their Open Offer application. The Company is asking shareholders to reply by Wednesday August 8th and that if no reply is received the Company will assume that the shareholder has accepted the proposal and confirmed their wish to apply for new ordinary shares as aforesaid and will allot the shares by using the funds held on the Registrars.

 

For further information, please contact:

 

Surface Transforms plc.

 

Kevin Johnson, CEO +44 151 356 2141

David Bundred, Chairman

 

Cantor Fitzgerald Europe (Nomad & Joint Broker) 

 

David Foreman, Michael Reynolds (Corporate Finance) +44 20 7894 7000

Mark Westcott, Alex Pollen (Sales)

 

finnCap Ltd (Joint Broker)

 

Stephen Norcross, Richard Chambers (Corporate Broking) +44 20 7220 0500

Ed Frisby, Giles Rolls (Corporate Finance)

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPBQLFLDDFFBBQ
Date   Source Headline
13th Nov 20234:56 pmRNSProposed Placing, Subscription and Open Offer
3rd Nov 20237:05 amRNSTrading Update
16th Oct 20237:00 amRNS£100m New Business Award from OEM 10
28th Sep 20231:55 pmEQSHardman & Co Research on Surface Transforms (SCE): Interim results
27th Sep 20237:00 amRNSInterim results for six months ended 30 June 2023
31st Jul 20237:00 amRNSPre-close trading update and operations update
20th Jul 20237:00 amRNSDirector Dealing
5th Jul 20237:00 amRNSHolding(s) in Company
27th Jun 20235:02 pmRNSResult of Annual General Meeting
27th Jun 20237:00 amRNSAGM Statement
26th Jun 20234:55 pmRNSExercise of Options and Total Voting Rights
21st Jun 20237:00 amRNSAward of LSE Green Economy Mark
20th Jun 202311:38 amRNSPDMR Dealing
19th Jun 20237:00 amRNSAppointment of new Chief Finance Officer
2nd Jun 20237:00 amRNSExercise of Options and Total Voting Rights
31st May 202312:51 pmRNSPosting of Annual Report and Notice of AGM
30th May 20237:00 amRNSAppointment of new Chief Operating Officer
23rd May 20237:00 amRNSExercise of Options and Total Voting Rights
18th May 20231:30 pmEQSHardman & Co Q&A on Surface Transforms (SCE): Production ramp up secured in a potential £2bn a year market
9th May 20237:30 amEQSHardman & Co Research on Surface Transforms (SCE): A major quantum production ramp up now secured
5th May 20237:00 amRNSDirector Dealing
27th Apr 202312:35 pmEQSHardman & Co Video | Surface Transforms (SCE) Presentation and Q&A with the Board
24th Apr 20237:00 amRNSHolding(s) in Company
24th Apr 20237:00 amRNSDirector dealing and total voting rights
17th Apr 20237:00 amRNSPreliminary Results and Notice of AGM
6th Apr 202312:45 pmEQSHardman Talks Video Event | Surface Transforms Management Presentation and Q&A
3rd Apr 20237:00 amRNSProduction, Capacity and Trading Update
27th Jan 20232:34 pmRNSHolding(s) in Company
11th Jan 20237:00 amRNSTrading and operations update
20th Dec 20227:00 amRNSDirectorate Change
19th Dec 20227:00 amRNSPDMR Share Dealing & Total Voting Rights
15th Dec 202210:22 amEQSHardman & Co Research : Surface Transforms (SCE): Major OEM 10 order, OEM 8 delay resolved
24th Nov 20227:00 amRNSOEM 10 Contract Award and Trading Update
9th Nov 20224:42 pmRNSExercise of Options
27th Oct 202211:05 amRNSHolding(s) in Company
24th Oct 202211:15 amRNSHolding(s) in Company
20th Oct 20228:01 amRNSDirector Dealing
19th Oct 202212:23 pmRNSResult of General Meeting & Total Voting Rights
19th Oct 20227:00 amRNSResult of Open Offer
6th Oct 20222:20 pmEQSHardman & Co Research on Surface Transforms (SCE): The large growth is now self-financing
6th Oct 202212:05 pmEQSHardman & Co: Hardman Talks Video | Surface Transforms Surface Transforms presentation and Q&A with the Board
30th Sep 202211:02 amRNSInvestor Presentation
29th Sep 20221:25 pmEQSHardman & Co Research : Hardman Talks Video Event | Surface Transforms Management Presentation and Q&A
29th Sep 20228:33 amRNSResult of Placing, Open Offer Launch & GM Notice
28th Sep 20225:03 pmRNSProposed Placing, Subscription and Open Offer
12th Sep 202212:00 pmEQSHardman & Co Q&A on Surface Transforms (SCE): It's all in the detail
6th Sep 20227:15 amEQSHardman & Co Research on Surface Transforms (SCE): Further new order, upgrades, production ramp-up
5th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSContract award from OEM 9
19th Aug 20227:00 amRNSRetirement of non-executive director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.